Rockville, MD, Oct. 1, 2024 (GLOBE NEWSWIRE) — Fact.MR Estimates Place the World Bone Mineral Densitometry (BMD) Market is estimated at a value of $351.2 million in 2024 and is projected to expand at a CAGR of 3.5% reach $495.1 million by the end of 2034.
Bone mineral densitometers are increasingly sought after due to their versatility and greater recognition in medicine. These devices, essential for assessing bone density, measuring fracture risk and diagnosing osteoporosis, are expanding their functions.
The aging of the world's population has intensified the demand for osteoporosis screening. Furthermore, densitometers now serve in various fields such as sports medicine, pediatrics, and even space exploration. They play a crucial role in monitoring bone disease treatments and assessing bone health in cancer patients. Their non-invasive nature and minimal radiation exposure make them ideal for widespread screening initiatives. Additionally, its ability to assess body composition has found application in fitness and nutrition. As awareness of bone health grows and densitometry finds new applications, the BMD market is poised for continued expansion.
To learn more about the market, request a sample of this report.
Key takeaways from the market study
- The global bone mineral densitometry market is anticipated to reach a size of $495.1 million by the end of 2034.
- East Asia is assessed to take into account 5% global market share by the end of 2034.
- The market in North America is expected to reach a valuation of 184 million dollars by 2034.
- By 2034, the BMD market in Canada is estimated to reach 18 million dollars.
- Based on the technology, sales of DXA devices are estimated at $225.9 million in 2024.
- According to end users, the hospital segment is expected to account for a market share of 5% in 2024.
“The increasing global incidence of osteoporosis and bone-related disorders is driving demand for bone mineral densitometry devices. Demographic shifts toward an older population, particularly postmenopausal women, who are at increased risk of osteoporosis and fractures, are driving the growth of the bone mineral densitometry market.” says a Fact.MR analyst.
Leading Players Driving Innovation in the Bone Mineral Densitometry Market:
GE Healthcare Hologic Inc.; DMS Images; Swissray International Inc.; Xingaoyi Medical Equipment Co. Ltd.; Eurotec Medical Systems; Trivitron Healthcare AB; Medonica Co. Ltd.; Diagnostic Medical Systems Group.
REMS technique and improving the efficiency of clinical 3D imaging offering and patient comfort
Improving clinical efficiency and patient comfort is paramount. Today, various devices with 3D imaging capabilities provide a comprehensive view of bone quality and structure, going beyond mere density assessments. Wearable and mobile technologies are improving access to bone health screenings, especially for bedridden people and those in remote areas. At the same time, integration with electronic medical records is streamlining workflows and enabling continuous patient monitoring.
Emerging technologies such as radiofrequency ultrasound multispectrometry (REMS) are advancing and offer radiation-free alternatives to traditional DXA scans. Additionally, algorithmic advances are creating opportunities for opportunistic detection of bone health using routine CT scans.
bone mineral densitometry Industry News:
- SOPHiA Genetics, a cloud-native software provider for the healthcare industry, announced in February 2023 that Synergy Laboratories, a full-service diagnostic laboratory in Alabama, will now use SOPHiA DDM to provide sophisticated cancer profiling solutions. Synergy Laboratories intends to use this cutting-edge platform for cancer research and clinical trials to expand the reach of its offerings.
- The U.S. Food and Drug Administration (FDA) announced in December 2022 that Mirati Therapeutics, a commercial-stage biotechnology company, received a breakthrough therapy designation (BTD) for adagrasib with cetuximab. This shows potential therapeutic action for people with advanced colorectal cancer that has a mutation in the KRAS gene.
Get customization of this report for specific research solutions.
More valuable information on offer
Fact.MR, in its new offering, presents an unbiased analysis of the bone mineral densitometry (BMD) market for 2019 to 2023 and forecast statistics for 2024 to 2034.
The study discloses essential information about the market based on product (axial bone densitometers, peripheral bone densitometers), technology (dual energy X-ray absorptiometry, dual energy peripheral X-ray absorptiometry, quantitative ultrasound) and end user (hospitals , orthopedic clinics, diagnostic centers), in seven major regions of the world (North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and the Pacific, and MEA).
Check out more related studies published by Fact.MR Research:
The world Bone and joint health supplements market. has been valued at $34.89 billion in 2024. Global sales of bone and joint health supplements are projected to grow at a CAGR of 7.5% and reach $71.91 billion by the end of 2034. .
The world Bone biopsy systems market. It is expected to enjoy a valuation of $227.6 million in 2022 and expand at a CAGR of 6% to reach $408.9 million by the end of 2032.
The world Bone cement and glue market It is expected to increase at a CAGR of 5.4% and rise from a market valuation of US$1.3 billion in 2022 to US$2.2 billion by the end of 2032. Demand for bone cement is expected to increase further fast at a CAGR of 6.2% through 2032
The world bone glue market Its size is estimated to reach $1.03 billion by 2024, according to new research published by Fact.MR. Global bone glue sales are projected to grow at a CAGR of 7.2% and reach $2.07 billion by the end of 2034.
The world bone grafts and substitutes market reached a valuation of $3.06 billion in 2020. Sales of bone grafts and substitutes are projected to grow at a CAGR of 4.9% to reach $4.44 billion by the end of 2028.
The world bone growth stimulator market It was valued at $1.89 billion in 2021. By 2022, the market is expected to reach a valuation of $1.99 billion, representing a year-on-year increase of 5.3%. During the forecast period of 2022-2032,
About us:
Fact.MR is a distinguished market research company recognized for its comprehensive market reports and valuable business insights. As a leading player in business intelligence, we offer deep analytics that uncover market trends, growth paths, and competitive landscapes. Recognized for its commitment to accuracy and reliability, we provide companies with crucial data and strategic recommendations, facilitating informed decision making and improving market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to help businesses face dynamic market challenges with confidence and achieve long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures that its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Follow us: LinkedIn |Twitter|blog
Contact: US Sales Office: 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Tel: +1 (628) 251-1583 Sales Team:sales@factmr.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.